SCHEMBL15312641

SCHEMBL15312641

CCOC(=O)c1ccc(-c2c(-c3cccs3)oc3cc(-c4ccsc4C(=O)O)ccc3c2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.39
▸ TSHR P16473 3/20 0.39
▸ TNKS O95271 1/20 0.39
▸ MAPT P10636 6/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ PRF1 P14222 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ KEAP1 Q14145 1/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HPGD P15428 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13836188 0.81 MAPT (0.52) ALDH1A1TSHRTNKSMAPTKDM4E
SCHEMBL15603247 0.79 MAPT (0.40) ALDH1A1TSHRTNKSMAPTKDM4E
SCHEMBL13835968 0.75 TNKS (0.38) ALDH1A1TSHRTNKSMAPTKDM4E
SCHEMBL2337593 0.74 KDM4E (0.48) ALDH1A1TSHRMAPTKDM4ETDP1
SCHEMBL2003093 0.69 MAPT (0.55) ALDH1A1TSHRMAPTKDM4ETDP1
SCHEMBL10624618 0.68 ALDH1A1 (0.52) ALDH1A1TSHRTNKSMAPTKDM4E
SCHEMBL11553562 0.68 ALDH1A1 (0.62) ALDH1A1TSHRTNKSMAPTKDM4E
SCHEMBL2332179 0.67 ALDH1A1 (0.44) ALDH1A1TSHRTNKSMAPTKDM4E
SCHEMBL2332646 0.65 ACP1 (0.53) ALDH1A1TSHRTNKSMAPTKDM4E
SCHEMBL28429289 0.65 KDM4E (0.54) ALDH1A1TSHRMAPTKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140163092-A1 Chromone Inhibitors of S-Nitrosoglutathione Reductase N30 PHARMACEUTICALS, INC. (US) 2014-06-12 — — US disclosed
US-8669381-B2 Chromone inhibitors of S-nitrosoglutathione reductase N30 PHARMACEUTICALS, INC. (US) 2014-03-11 — — US disclosed
US-20130274320-A1 Chromone Inhibitors of S-Nitrosoglutathione Reductase NIVALIS THERAPEUTICS, INC. 2013-10-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274320-A1 Chromone Inhibitors of S-Nitrosoglutathione Reductase POR, GSR, CBR1 ALDH1A1 363/4885TSHR 887/4885TNKS 3959/4885
US-20140163092-A1 Chromone Inhibitors of S-Nitrosoglutathione Reductase POR, GSR, CBR1 ALDH1A1 363/4885TSHR 887/4885TNKS 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback